Article (Scientific journals)
Speech and Voice Quality as Digital Biomarkers in Depression: A Systematic Review.
BRIGANTI, Giovanni; Lechien, Jérome
2025In Journal of Voice
Peer Reviewed verified by ORBi
 

Files


Full Text
1-s2.0-S0892199725001870-main.pdf
Author postprint (1.21 MB)
Download

All documents in ORBi UMONS are protected by a user license.

Send to



Details



Keywords :
Speech—Voice—Otolaryngology—Otorhinolaryngology—Laryngeal—Larynx—Acoustic—Biomarker—Mood monitoring—Machine learning—Artificial intelligence
Abstract :
[en] [en] OBJECTIVE: To review the current evidence on the use of artificial intelligence-driven speech and voice analysis as a biomarker for depression. METHODS: PubMed, Scopus, and Cochrane databases were reviewed by two independent investigators for studies investigating the use of artificial intelligence-driven speech and voice quality outcomes as biomarkers for depression according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statements. The methodological quality and risk of bias of each included study were assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. RESULTS: Of the 108 identified records, 12 studies met the inclusion criteria. The studies examined 16 872 participants, including patients with major depressive disorder (n = 1535), bipolar disorder (n = 111), schizophrenia spectrum disorders (n = 35), and anxiety disorders (n = 224). Control groups included a total of 1204 healthy individuals. Speech and voice quality outcomes consistently distinguished depression from controls (AUC = 0.71-0.93), with prosodic, spectral, and perturbation measures showing significant correlations with standardized depression scales. Classification accuracies ranged from 78% to 96.5%. Six studies demonstrated high risk of methodological bias, primarily in patient selection and validation techniques. Voice recording contexts varied between clinical settings and mobile technologies. CONCLUSION: The findings of this review highlight the potential of voice biomarkers as a novel tool for depression detection and monitoring. While current evidence demonstrates promising classification accuracy, methodological heterogeneity and generalizability concerns must be addressed before widespread clinical adoption.
Disciplines :
Psychiatry
Otolaryngology
Author, co-author :
BRIGANTI, Giovanni  ;  Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Médecine computationnelle et Neuropsychiatrie
Lechien, Jérome  ;  Université de Mons - UMONS > Faculté de Psychologie et des Sciences de l'Education > Service de Métrologie et Sciences du langage ; Université de Mons - UMONS > Faculté de Médecine, Pharmacie et Sciences Biomédicales > Service de Chirurgie ; Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Chirurgie
Language :
English
Title :
Speech and Voice Quality as Digital Biomarkers in Depression: A Systematic Review.
Publication date :
22 May 2025
Journal title :
Journal of Voice
ISSN :
0892-1997
eISSN :
1873-4588
Publisher :
Elsevier BV, United States
Peer reviewed :
Peer Reviewed verified by ORBi
Research unit :
M120 - Service de Chirurgie
M121 - Service de Médecine computationnelle et Neuropsychiatrie
Research institute :
Santé
Available on ORBi UMONS :
since 17 October 2025

Statistics


Number of views
71 (2 by UMONS)
Number of downloads
491 (2 by UMONS)

Scopus citations®
 
12
Scopus citations®
without self-citations
11
OpenCitations
 
0
OpenAlex citations
 
9

Bibliography


Similar publications



Contact ORBi UMONS